Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omeros Corp (OMER)

Omeros Corp (OMER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,089,024
  • Shares Outstanding, K 70,900
  • Annual Sales, $ 0 K
  • Annual Income, $ -156,820 K
  • EBIT $ -129 M
  • EBITDA $ -127 M
  • 60-Month Beta 2.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 108.53% (-21.76%)
  • Historical Volatility 192.68%
  • IV Percentile 52%
  • IV Rank 16.95%
  • IV High 355.15% on 05/16/25
  • IV Low 58.19% on 02/13/25
  • Expected Move (DTE 21) 2.86 (18.18%)
  • Put/Call Vol Ratio 0.42
  • Today's Volume 12,931
  • Volume Avg (30-Day) 7,944
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 121,308
  • Open Int (30-Day) 110,942
  • Expected Range 12.85 to 18.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.55
  • Number of Estimates 1
  • High Estimate -0.55
  • Low Estimate -0.55
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +12.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.27 +89.96%
on 12/16/25
17.65 -10.99%
on 12/24/25
+6.08 (+63.14%)
since 11/26/25
3-Month
4.05 +287.42%
on 10/14/25
17.65 -10.99%
on 12/24/25
+11.25 (+252.24%)
since 09/26/25
52-Week
2.95 +432.54%
on 07/01/25
17.65 -10.99%
on 12/24/25
+5.25 (+50.19%)
since 12/26/24

Most Recent Stories

More News
Omeros Announces New Date for YARTEMLEA® Approval Conference Call

— Omeros to Host Conference Call Wednesday, January 7, 2026 at 4:30 p.m. ET —

OMER : 15.71 (+2.28%)
FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

– Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET –   First and only approved option: YARTEMLEA ®...

OMER : 15.71 (+2.28%)
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)

Omeros Corporation (Nasdaq: OMER) today announced the closing of the asset sale and licensing transaction between Omeros and Novo Nordisk for the candidate drug zaltenibart (formerly OMS906). Zaltenibart...

OMER : 15.71 (+2.28%)
Omeros: Q3 Earnings Snapshot

Omeros: Q3 Earnings Snapshot

OMER : 15.71 (+2.28%)
Omeros Corporation Reports Third Quarter 2025 Financial Results

– Conference Call Today at 4:30 p.m. ET

OMER : 15.71 (+2.28%)
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended September 30, 2025, on Thursday, November 13, 2025, after the market closes. Omeros...

OMER : 15.71 (+2.28%)
Breakout Momentum Plays You Need to Know About

Three stocks may draw the attention of momentum investors—QURE spiked in September, OMER in October, and SDST has almost 1,000% in upside potential.

QURE : 24.81 (-1.51%)
SDST : 3.16 (+2.27%)
NVO : 52.40 (-0.30%)
OGE : 42.78 (-0.49%)
OMER : 15.71 (+2.28%)
Breakout Momentum Plays You Need to Know About

Three stocks may draw the attention of momentum investors—QURE spiked in September, OMER in October, and SDST has almost 1,000% in upside potential.

QURE : 24.81 (-1.51%)
SDST : 3.16 (+2.27%)
NVO : 52.40 (-0.30%)
OGE : 42.78 (-0.49%)
OMER : 15.71 (+2.28%)
Needham Sticks to Its Hold Rating for Omeros (OMER)

In a report released today, Serge Belanger from Needham maintained a Hold rating on Omeros. The company’s shares opened today at $11.59.Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

OMER : 15.71 (+2.28%)
Omeros Signs Major Deal with Novo Nordisk

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Omeros (...

OMER : 15.71 (+2.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM)...

See More

Key Turning Points

3rd Resistance Point 17.98
2nd Resistance Point 16.92
1st Resistance Point 16.32
Last Price 15.71
1st Support Level 14.66
2nd Support Level 13.60
3rd Support Level 13.00

See More

52-Week High 17.65
Last Price 15.71
Fibonacci 61.8% 12.03
Fibonacci 50% 10.30
Fibonacci 38.2% 8.57
52-Week Low 2.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar